Editor's Choice

Debate recap: Bird Flu Research

Two pathologists dissect a swan in the Danish Food Research Center in Aarhus, Jutland, February 16, 2006. Europe began locking up its one-billion-strong chicken flock on Wednesday after the deadly bird flu virus was found in two more countries on the continent, dealing another blow to battered poultry producers. Germany and Austria are the latest EU countries to report the discovery of dead swans infected with the H5N1 strain of avian influenza, which has spread from Asia to Africa, killed 91 people and led to the destruction of millions of birds. NORWAY OUT DENMARK OUT SWEDEN OUT NO THIRD PARTY SALES REUTERS/Henning Bagger/Scanpix

Dangerous information on a deadly virus

A call to censor scientific research on the deadly bird flu virus has global health officials debating whether such studies are worth the risk. Read our recap of a Harvard School of Public Health discussion on this subject, presented in collaboration with Reuters.  Learn More 

Drug-dispensing contact lens passes early tests

Related Topics

A contact lens is shown in Somerville, Massachusetts June 10, 2008. REUTERS/Brian Snyder

A contact lens is shown in Somerville, Massachusetts June 10, 2008.

Credit: Reuters/Brian Snyder

NEW YORK | Tue Aug 4, 2009 3:23pm EDT

NEW YORK (Reuters Health) - A contact lens that gradually dispenses a steady stream of medication to the eye could ease treatment for glaucoma and other eye ailments if it advances through animal and human testing, according to new research.

For people who need eye drops for conditions such as glaucoma -- damage to the nerve that connects the eye to the brain -- using them several times a day is burdensome and inefficient. Due to natural blinking and tearing, typically only a little bit of the medication is absorbed by the eye. The drug-dispensing contact lens may boost convenience and effectiveness, say authors of the study.

Laboratory tests show that the drug-dispensing contact lens "can release really large amounts of drug for very long periods of time at a very steady rate," Dr. Daniel Kohane, director of the Laboratory for Biomaterials and Drug Delivery at Children's Hospital Boston, noted in a telephone interview with Reuters Health.

Kohane collaborated with Dr. Joseph Ciolino of the Massachusetts Eye and Ear Infirmary and colleagues at the Department of Chemical Engineering at the Massachusetts Institute of Technology to develop the drug-dispensing contact lens.

Although other groups have developed drug-releasing contact lenses, none have been able to achieve a constant, steady stream of medication at high enough levels to be therapeutic, the researchers note in the journal Investigative Ophthalmology and Visual Science. Prior contact lenses "have released very small amounts of drug for long periods of time or a lot of drug for not a long time," Kohane said.

In the lab tests, contact lens Kohane's team developed dispensed appropriate levels of ciprofloxacin -- an antibiotic used in eye drops -- for 30 days and in some tests for as long as 100 days. "We're talking really large levels of the drug, for example, enough antibiotic to still be effective for that long," Kohane said.

The drug-dispensing contact lenses are the size and thickness of commercially available contact lenses. The researchers have begun testing them in animals and hope to begin human testing soon.

Drug-dispensing contact lenses "could be used with almost any drug that could be applied to the eye, particularly the front of the eye, and for a range of conditions such as glaucoma, allergic conjunctivitis, dry eye, infections, pain, and things like that," Kohane noted.

SOURCE: Investigative Ophthalmology and Visual Science, July 2009.

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.